In a recent research performed by the ITN and sponsored by NIAID, NIH portrayed that the stem-cell transplanting leads to another great hope in the fight against multiple sclerosis. As per the survey, the stem cell transplants conducted on the individual cells of selected people showed long-term eradication of MS symptoms. The HDIT/HCT (High-Dose Immunosuppressive Therapy & Autologous Hematopoietic Cell Transplant) treatment is showing promising results as Dr. Shiva Gopal Vasishta added. Nearly 70% of the participants showed no brain lesions, side effects, or relapse symptoms.
Stem cell transplants may bring about long-term remission in multiple sclerosis with the experiment seeking to suppress active diseases and prevent more disability by resetting the immune system and by eradicating the disease-causing cells. Even though more research on the same is going on, it seems that the medication is more powerful as compared to the MS drugs, which are often prescribed medication. The HALT-MS survey evaluated the HDIT/HCT within 24 clinical subjects where the participants’ ages varied from 26 to 52 years, and who in spite of receiving MS medication, their conditions deteriorated. Amidst research, the HDIT/HCT treatment is turning into a modern way of treating people who don’t respond positively to other medications.
Dr. Shiva Gopal Vasishta is a psychiatrist and neurologist based in New-Jersey and presently works alongside the team at the Kennedy University of Hospital. Shiva graduated in 1979 from the Government Medical College in Nagpur. An expert in the sector, his experience is over 40 years. Dr. Shiva Gopal Vasishta also finished his post-graduate medical courses from Boston City Hospital. His experience and skills are transforming the sector and at the same time helping various kinds of patients.
The specialist is a licensed neurology who operates from Voorhees, New Jersey. Dr. Shiva Gopal Vasishta runs a modern medical center that accepts various kinds of insurance covers from various companies such as Aetna, Horizon Blue, and Blue Cross Blue Shield among others.